Literature DB >> 11597819

The effects of citicoline and/or MK-801 on survival, neurological and behavioral outcome of mice exposed to transient hyperglycemia and oligemic hypoxia.

K Rejdak1, R Rejdak, M Sieklucka-Dziuba, Z Stelmasiak, P Grieb.   

Abstract

UNLABELLED: The effects of citicoline and/or low dose of MK-801 (sufficient to prevent the development of seizures) on survival, neurological and behavioral recovery following transient hyperglycemic-oligemic-hypoxic insult have been evaluated in mice. Neurological recovery was assessed semi-quantitatively on the third and the 10th day after the insult, and behavioral tests evaluating spontaneous locomotor activity, motor coordination and spontaneous alternation performance were performed on day 10. Neither drug given alone did influence survival rate, but the combination of MK-801 and higher citicoline dose decreased mortality on day 10. Behavioral performance was markedly compromised by the insult. Citicoline, but not MK-801, slightly but significantly improved behavioral outcome in all three tests.
CONCLUSION: when brain ischemic insult is complicated with acute hyperglycemia, post-treatment with citicoline combined with MK-801 in low anti-convulsive dose improves survival and neurological recovery, and citicoline but not MK-801 enhances behavioral recovery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597819     DOI: 10.1016/s0924-977x(01)00107-9

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  4 in total

Review 1.  Glucose and outcome after cardiac surgery: what are the issues?

Authors:  Hilary P Grocott
Journal:  J Extra Corpor Technol       Date:  2006-03

Review 2.  Neuroprotection during cardiac surgery.

Authors:  Hilary P Grocott; Kenji Yoshitani
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

Review 3.  Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis.

Authors:  Niall J J MacDougall; Keith W Muir
Journal:  J Cereb Blood Flow Metab       Date:  2010-12-15       Impact factor: 6.200

Review 4.  An unmet clinical need: roads to remyelination in MS.

Authors:  Peter Göttle; Moritz Förster; Vivien Weyers; Patrick Küry; Konrad Rejdak; Hans-Peter Hartung; David Kremer
Journal:  Neurol Res Pract       Date:  2019-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.